Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Toujeo generated Sanofi €1.12 Additional revenue came from the acquisition of Alexion Pharmaceuticals in July 2021. billion ($1.17
Let's personalize your content